Xcout IntelSign inSubscribe

Keros

BiotechUnited States

Keros Therapeutics is a clinical-stage biopharmaceutical company that develops novel therapeutics targeting the transforming growth factor-beta (TGF-ß) superfamily of proteins. The company focuses on creating treatments for patients with hematological and neuromuscular disorders linked to dysfunctional protein signaling.

Subscribe to see Keros’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Keros at a glance

Keros is a biotech company headquartered in United States. Its most recent funding round, Series C, raised $56M in March 2020. Xcout tracks 11 named people at Keros, including Jasbir Seehra, Ph.D. (President, Chief Executive Officer and Director). Xcout recorded 37 job postings from Keros in the last 90 days.

Industry
Biotech
Headquarters
United States
Job postings recorded (90 days)
37
Xcout AI Rank
0/100 ▼
Xcout Green Rank
0/100

Keros leadership

  • Jasbir Seehra, Ph.D.President, Chief Executive Officer and Director
  • Esther Cho, J.D.Chief Legal Officer
  • Lorena Lerner, Ph.D.Chief Scientific Officer
  • Annita Tanini, M.B.A.Corporate Controller and Vice President, Finance
  • Jean-Jacques Bienaimé, M.B.A.Chairman
  • Alpna Seth, Ph.D.Member of our board of directors

5 more named people on record for Keros, with roles, board committees and tenure — see the full roster →

Keros funding rounds

Every round on record:

DateRoundAmountInvestors
Series C$56M1 named

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Hiring at Keros

Xcout recorded 37 job postings from Keros in the last 90 days, from a hiring record Xcout has kept since July 2026.

The weekly hiring trend, the roles and locations behind it — see Keros's hiring signals →

Investors

Tech stack

AzureGCP

Get Keros's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Keros — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Keros in Xcout Intel

  • 11 named people with titles, LinkedIn and board committees
  • 1 funding round with the investors in each, and who they co-invest with
  • Weekly hiring history and the mix of roles behind it
  • 1 corporate event with sources — deals, leadership changes, layoffs
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →